GLI1 and pancreatic neoplasm: On the other hand, the expression of IGF2 was very low in pancreatic cancer and was not affected by cyclopamine or RNAi for Gli1, which means the regulation of IGF2 expression is independent of Shh-Gli1 signaling pathway in pancreatic cancer.